ESC Premium Access

Glycated haemoglobin and risk of all-cause, causal mortality and cardiovascular hospitalisation in type 2 diabetes mellitus according to body mass index.

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Congress Presentation

About the speaker

Doctor Oliver Ian Brown

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)
0 follower

10 more presentations in this session

Baseline insulin levels are associated with need for revascularization among diabetic patients with high risk vascular disease: insights from the ACCELERATE trial

Speaker: Doctor V. Menon (Cleveland, US)

Thumbnail

Regional differences in the incidence of acute coronary syndrome and ischemic stroke in diabetic populations reflect differences in the quality of diabetes care

Speaker: Doctor K. Winell (Helsinki, FI)

Thumbnail

Protein oxidation and cardiovascular disease in patients with type 2 diabetes.

Speaker: Miss A. Bryk (Krakow, PL)

Thumbnail

Severity of retinopathy and coronary artery calcium score in type 1 and type 2 diabetic patients

Speaker: Doctor G. Achkouty (Beirut, LB)

Thumbnail

Isolated systolic hypertension and combined systolic-diastolic hypertension for prediction of new-onset diabetes mellitus: Data from a 8-year-follow-up study

Speaker: Doctor D. Konstantinidis (Athens, GR)

Thumbnail

Access the full session

Poster Session 5 - Diabetes, obesity and metabolic syndrome

Speakers: Doctor O. Brown, Doctor V. Menon, Doctor K. Winell, Miss A. Bryk, Doctor G. Achkouty...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb